Table 2.
Palpitations findings from two or three groups articles of drug therapies and non-drug therapies (n=24).
| 1st author year | Placebo benefit | Treatment benefit | Comparison of treatment and placebo benefit | ||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| No | Yes | No | Yes | Same | Difference | ||
| DRUG THERAPIES (n=13) | |||||||
| Hormonal agents (n=12) | |||||||
| Anarte 1998 [36] | √ | ♦ | HT + psychological treatment > HT | ||||
| √ | |||||||
|
| |||||||
| Carmignani 2010 [38] | ● | √ | ♦ | HT = Isoflavone = placebo | |||
| √ | |||||||
|
| |||||||
| Checa 2005 [39] | √ | ♦ | HT > Calcium or raloxifene at 6 not 12 months | ||||
| √ | |||||||
| √ | |||||||
|
| |||||||
| Elfituri 2005 [41] | √ | ♦ | Estradiol+dydrogesterone = Tibolone | ||||
| √ | |||||||
|
| |||||||
| Fluck 2002 [49] | √ | ♦ | Tibolone > untreated group | ||||
|
| |||||||
| Kim 2019 [42] | √ | ♦ | Estrogen = Tibolone | ||||
| √ | |||||||
|
| |||||||
| Moyer 2018 [43] | ● | √ | ♦ | oCEE = Transdermal E = placebo | |||
| √ | |||||||
|
| |||||||
| Nevinny-Stickel 1983 [50] | ● | √ | ♦ | Org OD 14 = placebo | |||
|
| |||||||
| Polo-Kantola 1998 [44] | ● | √ | ♦ | HT = placebo | |||
|
| |||||||
| Pornel 1996 [45] | √ | ♦ | (HT) Menorest = Premarin = Estraderm | ||||
| √ | |||||||
| √ | |||||||
|
| |||||||
| Takamatsu 2001 [46] | √ | ♦ | HT < Counseling | ||||
| √ | |||||||
|
| |||||||
| Tit 2017 [47] | √ | HT, isoflavones not reported | |||||
| √ | |||||||
|
Non-hormonal drug therapies (n=1) | |||||||
| Kujala 2014 [54] | √ | ♦ | Moxonidine = Atenolol | ||||
| √ | |||||||
|
NON-DRUG THERAPIES (n=11) | |||||||
| Supplementary treatments - isoflavones&other phytoestrogens (n=4) | |||||||
| Agosta 2011[55] | √ | ♦ | Estromineral = Estromineral Serena | ||||
| √ | |||||||
|
| |||||||
| Auerbach 2012 [57] | ● | √ | ♦ |
Pomegranate seed oil = placebo | |||
|
| |||||||
| Costa 2017 [58] | √ | ♦ | Isoflavone + exercise = Placebo + exercise | ||||
| √ | |||||||
|
| |||||||
| Davinelli 2017 [59] | ● | √ | ♦ | Equopausa (resveratrol) > placebo | |||
|
Supplementary treatments - Rheum rhaponticum (n=3) | |||||||
| Hasper 2009 [60] | ● | √ | ♦ | ERr 731 = placebo | |||
|
| |||||||
| Heger 2006 [61] | ● | √ | ♦ | ERr 731 > placebo | |||
|
| |||||||
| Kaszkin-Bettag 2009 [62] | ● | √ | ♦ | ERr 731 > placebo | |||
|
Supplementary treatments - Salvia officinalis or sage (n=1) | |||||||
| Zeidabadi 2020 [65] | ● | √ | ♦ | Salvia officinalis extract > placebo | |||
|
Supplementary treatments - other (n=2) | |||||||
| Fatima 2017 [66] | ● | √ | ♦ | Tribulus terrestris L. > placebo | |||
|
| |||||||
| Park & Kim, 2016 [69] | ● | √ | ♦ | Schisandra chinensis > placebo | |||
|
Psychological intervention (n=1) | |||||||
| Qian 2010 [71] | √ | √ | ♦ | Psychological + herbals > single treatment | |||
| √ | |||||||
> indicates that one intervention is superior to another one or placebos; = indicates no effect difference between interventions and/or placebos.
HT = hormonal therapy, oCEE = oral conjugated equine estrogen, ERr 731 = a special extract of Rheum rhaponticum.